How to Source Ivermectin Tablets from India

Quick answer: India is one of the world’s largest producers of generic ivermectin tablets, with manufacturing concentrated in Gujarat, Himachal Pradesh, Andhra Pradesh, and Telangana. Sourcing reliably means verifying the manufacturer’s WHO-GMP certification (and any additional GMP recognition your destination market requires), confirming the specific product’s regulatory status in your target country, checking API sourcing and batch documentation, and working through a supplier who can produce a Certificate of Pharmaceutical Product (COPP) and export documentation matched to your country’s import requirements. Minimum order quantities, lead times, and pricing vary significantly between manufacturers, so due diligence on the facility and its compliance history matters more than comparing quotes on price alone.

If you’re a distributor, wholesaler, or NGO procurement lead looking to source ivermectin tablets, India is very likely already on your shortlist — and for good reason. The country manufactures a substantial share of the world’s generic ivermectin supply, at price points and production scale that few other origins can match. But “India makes a lot of ivermectin” isn’t the same as “any Indian manufacturer is a safe bet,” and the difference between a smooth, repeatable sourcing relationship and a shipment stuck at customs usually comes down to how carefully you verify the supplier before the first purchase order goes out.

This guide walks through where ivermectin manufacturing is concentrated in India, what to check before committing to a supplier, how the export and documentation process typically works, and the mistakes that trip up first-time buyers most often.

Key Takeaways

• India’s ivermectin manufacturing is concentrated in a handful of pharma clusters — Gujarat (Ahmedabad, Vadodara, Vapi), Himachal Pradesh (Baddi), and Andhra Pradesh/Telangana (Hyderabad region).
• WHO-GMP certification is the baseline to verify, but your destination market may require additional recognition (FDA, EU-GMP, MHRA, TGA, or MOHAP-specific evidence) depending on where you’re importing to.
• A genuine Certificate of Pharmaceutical Product (COPP), tied to the exact manufacturing site and product, is essential documentation for most international import registration processes.
• Minimum order quantities and lead times vary widely between manufacturers — larger, more established exporters often have higher MOQs but more predictable supply.
• Batch-specific Certificates of Analysis and independent verification of GMP status should be standard practice for every new supplier relationship, not a one-time check.

Why India Dominates Global Ivermectin Supply

India’s position as a major ivermectin producer isn’t accidental — it reflects the broader strength of the country’s generic pharmaceutical manufacturing base. India supplies a significant share of the world’s generic medicines by volume, built on decades of API (Active Pharmaceutical Ingredient) manufacturing capability, a large pool of pharmaceutical chemistry and quality assurance talent, and manufacturing costs that remain competitive relative to many other producing countries.

For a molecule like ivermectin — off-patent, well-established, and manufactured at scale for both human and veterinary use — Indian manufacturers have had decades to refine production processes, and the country’s manufacturing base includes both the API production (the actual ivermectin compound) and the finished dosage form manufacturing (tablets, dispersible tablets) often within the same corporate groups or closely linked supply chains. This vertical integration is part of why Indian-sourced ivermectin tablets are often price-competitive without necessarily sacrificing quality, provided you’re sourcing from a properly certified facility.

Where Ivermectin Manufacturing Is Concentrated in India

Gujarat

Gujarat is home to one of India’s largest pharmaceutical manufacturing clusters, with significant API and formulation manufacturing concentrated around Ahmedabad, Vadodara, and Vapi. The state’s manufacturing base benefits from established port access (Mundra and Kandla ports serve as major export gateways), a mature regulatory ecosystem with the Gujarat Food and Drug Control Administration overseeing state-level GMP inspections, and a dense network of API suppliers that reduces logistics friction for formulation manufacturers sourcing raw ivermectin.

Himachal Pradesh (Baddi-Baroti-Nalagarh Belt)

The Baddi region in Himachal Pradesh has grown into one of India’s most concentrated pharmaceutical manufacturing zones, driven substantially by state tax incentives that attracted major and mid-sized manufacturers over the past two decades. A significant share of India’s formulation manufacturing — including tablets, capsules, and other finished dosage forms — happens in this belt, and it’s a common origin point for generic ivermectin tablet production specifically.

Andhra Pradesh and Telangana (Hyderabad Region)

The Hyderabad pharmaceutical cluster, sometimes referred to informally as India’s “Genome Valley” and broader pharma hub, hosts a mix of large multinational-linked API producers and formulation manufacturers, with particular strength in bulk drug (API) manufacturing that feeds both domestic and export-oriented tablet production elsewhere in the country.

Other Notable Regions

Maharashtra (particularly around Mumbai and Aurangabad) and parts of Uttar Pradesh also host meaningful pharmaceutical manufacturing activity relevant to antiparasitic drug production, though at generally smaller scale relative to the three clusters above for ivermectin specifically.

What to Verify Before Committing to a Supplier

1. WHO-GMP Certification, Verified Independently

As covered in more depth in our guide to how WHO-GMP certification works, this is the baseline compliance credential for most international ivermectin trade. Don’t take a supplier’s certificate at face value — verify the certificate number, issuing State Drug Controller, facility address, and product scope directly with the issuing authority, or at minimum cross-check the documentation for internal consistency (address matches, dates are current, product categories align with what you’re ordering).

2. Additional GMP Recognition for Your Specific Destination Market

WHO-GMP alone doesn’t automatically satisfy every importing country’s requirements. If you’re sourcing for the US, confirm the facility has FDA registration and, if the product needs to be marketed there, an approved ANDA. If you’re sourcing for the UK, confirm GMP recognition falls under a pathway the MHRA accepts. If you’re sourcing for Australia, confirm TGA GMP clearance status. If you’re sourcing for the UAE or similar WHO-GMP-recognising markets, a properly issued Certificate of Pharmaceutical Product alongside WHO-GMP is usually the more direct pathway. Assuming one certification opens every market is one of the most common and costly mistakes in this category.

3. API Source and Traceability

Ask where the manufacturer sources its ivermectin API — whether they manufacture it in-house or source it from a separate API supplier — and request documentation establishing traceability. Facilities with in-house or closely integrated API production often have tighter quality control over the full manufacturing chain, though a well-managed relationship with a reputable external API supplier can work just as well, provided the traceability documentation is solid.

4. Product Registration Status in Your Target Country

Confirm whether the specific product already holds registration or approval in your destination market, or whether you’ll need to initiate that process. A manufacturer with existing registrations in markets similar to yours (other WHO-GMP-recognising countries, for instance) often signals both regulatory experience and a smoother path for your own market entry.

5. Batch Documentation and Quality Systems

Request sample Certificates of Analysis, ask about their deviation and CAPA (Corrective and Preventive Action) process, and where possible, ask for a summary of their site master file. Manufacturers confident in their quality systems generally don’t hesitate to share this kind of documentation.

6. Export Experience and Track Record

Ask directly about the manufacturer’s export history — which countries they currently supply, how long they’ve held their export relationships, and whether they can provide references or examples of successful shipments to markets similar to yours. A facility that’s WHO-GMP certified but has limited actual export experience carries more execution risk than one with a demonstrated multi-year track record, even if the underlying certification looks identical on paper.

Understanding Minimum Order Quantities and Pricing

Minimum order quantities for ivermectin tablets from Indian manufacturers vary considerably depending on the manufacturer’s scale and typical customer base. Larger, more established exporters — often supplying institutional buyers, NGOs, and large distributors — may set MOQs in the range of hundreds of thousands to millions of tablets, reflecting their production batch sizes and cost structure. Smaller or mid-sized manufacturers, more accustomed to serving smaller distributors or newer market entrants, may offer more flexible MOQs, sometimes considerably lower, though often at a somewhat higher per-unit cost given reduced economies of scale.

Pricing itself depends on strength (3mg, 6mg, 12mg, or dispersible formats generally carry different per-unit costs), order volume, packaging requirements (blister packs versus bulk, specific labeling requirements for your market), and payment terms. It’s worth approaching price comparisons across suppliers with some caution — a quote that’s dramatically below the range other WHO-GMP certified manufacturers are offering is worth investigating rather than simply accepting, since compliance overhead (facility maintenance, quality systems, regulatory documentation) is a real and largely fixed cost that a legitimate certified manufacturer needs to recover somewhere in their pricing.

The Export Documentation You Should Expect

A well-organized Indian ivermectin manufacturer should be able to provide, as standard practice for an international order:

• Certificate of Pharmaceutical Product (COPP), referencing the correct manufacturing site and product, issued under the WHO certification scheme
• WHO-GMP certificate, current and matched to the facility producing your specific order
• Certificate of Analysis (CoA), batch-specific, for each shipment
• Free Sale Certificate, where applicable, confirming the product is legally sold in India or another reference market
• Commercial invoice and packing list, consistent with the declared shipment
• Certificate of Origin, for customs purposes in your destination country
• Product labeling and package insert, matched to your destination market’s language and regulatory requirements

If a manufacturer struggles to produce this documentation promptly, or seems unfamiliar with what a specific document is or why you’re requesting it, that’s a meaningful signal about their actual export experience, regardless of how their marketing materials present them.

Step-by-Step: A Practical Sourcing Process

1. Define Your Regulatory Requirements First

Before contacting any manufacturer, confirm exactly what your destination market requires — GMP recognition pathway, product registration status, labeling language, and any specific documentation your customs process will expect. Sourcing decisions made without this groundwork often result in choosing a supplier who can’t actually clear your specific market.

2. Build a Shortlist Based on Compliance Credentials, Not Just Price

Identify manufacturers with WHO-GMP certification (and any additional recognition your market requires) covering the relevant product category, rather than starting from a price-sorted list.

3. Request and Independently Verify Documentation

Ask for the WHO-GMP certificate, COPP, and site master file summary, and verify the certificate details directly with the issuing state authority rather than relying solely on the documents as provided.

4. Request Samples and Batch Documentation

For a new supplier relationship, requesting product samples along with their associated Certificate of Analysis lets you independently verify quality claims before committing to a full order.

5. Negotiate Terms With MOQ and Lead Time Clarity

Confirm minimum order quantities, production lead times, and payment terms clearly upfront, and build realistic expectations around how long production and shipping will actually take, rather than relying on optimistic best-case timelines.

6. Establish a Quality Agreement

For any ongoing supply relationship, a written quality agreement covering specifications, testing protocols, change notification, and recall procedures gives you contractual recourse beyond what certification documentation alone provides.

7. Plan Logistics and Customs Clearance in Advance

Confirm with your customs broker or import compliance team what documentation your destination country’s customs process will require, and build this into your purchase order checklist so nothing is assembled reactively after the shipment has already left India.

8. Build in Ongoing Verification, Not Just a One-Time Check

Certification status, Import Alert or equivalent flags, and regulatory standing can change over time. Periodically re-verify your supplier’s compliance status, particularly for high-volume or long-term relationships.

Realistic Timeline and Cost Considerations

For a first-time order with a new supplier, buyers should realistically plan for two to four months from initial outreach to product arriving at the destination port, factoring in the verification steps that shouldn’t be skipped even though they add time upfront. Repeat orders with an established, trusted supplier typically move considerably faster once the relationship and documentation patterns are established.

On cost, per-tablet pricing for ivermectin varies with strength, order volume, and packaging format, and is also affected by broader factors like API price fluctuations and currency exchange movements. Rather than anchoring on a single expected price point, it’s more useful to request comparable quotes from two or three verified, WHO-GMP certified manufacturers for the same specification and volume, which gives a realistic sense of the current competitive range rather than relying on outdated pricing expectations from a previous sourcing cycle.

Shipping and Logistics Considerations

Beyond the manufacturing and compliance side, the logistics leg of sourcing from India deserves its own attention, since it’s a common source of delay even when the underlying product and documentation are fully in order.

Port selection matters. Depending on your manufacturer’s location, shipments typically move through Mundra, Kandla, Nhava Sheva (JNPT near Mumbai), or Chennai, and transit times to your destination port vary meaningfully depending on which Indian port your supplier uses and the shipping routes available from there. If you have flexibility, working with a manufacturer whose nearest port has established, frequent shipping routes to your destination can shave real time off your overall timeline.

Temperature and storage requirements during transit. While ivermectin tablets are generally more storage-stable than some other pharmaceutical products, confirming appropriate storage conditions are maintained throughout transit — particularly for shipments moving through hot climates or extended transit times — is worth building into your logistics planning and freight forwarder briefing.

Freight forwarder experience with pharmaceutical shipments matters. As covered in more depth in our guide to FDA import requirements, a freight forwarder or customs broker experienced specifically with pharmaceutical shipments will generally anticipate documentation requirements and potential friction points more effectively than one primarily handling general cargo, and this experience gap becomes especially relevant when a shipment does get flagged for additional review at your destination port.

Insurance and risk allocation. Confirm cargo insurance coverage and clarify contractually who bears responsibility for loss or damage at each stage of the shipment — from the manufacturer’s warehouse through to your own receiving facility — since gaps in this coverage can turn a logistics hiccup into a significant financial loss.

Common Mistakes First-Time Buyers Make

Choosing a supplier based primarily on price. As covered above, unusually low pricing relative to other certified manufacturers is a signal worth investigating, not a straightforward win.

Assuming WHO-GMP alone clears every destination market. This is one of the most consistent mistakes across every regulated market covered in our broader compliance guides — verify what your specific destination actually requires.

Not verifying the certificate against the actual manufacturing site. Suppliers sometimes hold certification for one facility while product is actually manufactured, in whole or part, elsewhere. Always confirm the address on the certificate matches where your specific order is being produced.

Skipping a quality agreement for ongoing relationships. A strong first shipment doesn’t guarantee consistency on the fifth or the fiftieth. A written quality agreement protects you as the relationship scales.

Underestimating lead times. Between production scheduling, quality release, and international shipping, realistic timelines are often longer than a manufacturer’s initial optimistic quote, particularly for a first order with a new supplier still calibrating to your specific requirements.

Not confirming labeling and packaging requirements early. Products manufactured with India-market or another export market’s labeling won’t automatically satisfy your destination country’s requirements — confirm this before production begins, not after the shipment arrives.

Evaluating Manufacturer Scale and Reliability

Beyond compliance credentials, it’s worth assessing whether a manufacturer’s scale and operational maturity actually match your intended order pattern, since a mismatch here creates real risk even when certification is fully in order.

For large, recurring orders, an established manufacturer with substantial production capacity, multiple product lines, and a track record of supplying institutional or NGO buyers is generally the safer choice, even if their MOQs and lead times are less flexible than a smaller operation’s. These manufacturers typically have more robust quality systems simply because they’ve had to build infrastructure capable of handling larger-scale scrutiny from a wider range of international customers and regulators.

For smaller or first-time orders, a mid-sized manufacturer more accustomed to working with newer distributors may offer a better fit, provided their WHO-GMP certification and documentation practices check out under the same scrutiny you’d apply to a larger candidate. Don’t let a manufacturer’s smaller scale become a reason to skip verification steps — if anything, it’s worth being somewhat more thorough, since smaller operations sometimes have less mature documentation and quality systems even when their core manufacturing process is sound.

Ask about capacity utilization and backup production plans. A manufacturer operating near full capacity may struggle to meet your delivery timeline if unexpected demand from other customers arises, while a facility with meaningful spare capacity is generally better positioned to accommodate reorders or volume increases without extending your lead times. It’s a reasonable question to ask directly during supplier evaluation, and a transparent answer is itself a positive signal about the manufacturer’s overall operational maturity.

Sourcing for NGO and MDA Procurement Specifically

For NGO procurement teams and organizations supplying mass drug administration programs, sourcing considerations extend somewhat beyond standard commercial distribution. WHO Prequalification is frequently a requirement for UN agency and major donor-funded procurement (UNICEF, Global Fund, and similar bodies), and this is a distinct, more rigorous evaluation than standard WHO-GMP certification — not every WHO-GMP certified manufacturer’s products are WHO-prequalified, and confirming this distinction early in the sourcing process avoids a supplier being disqualified late in a tender process.

Bulk packaging formats, program-specific labeling (including donation program markings where applicable), and large-volume production capacity all matter more in this procurement context than in standard commercial distribution, and manufacturers with established MDA program supply experience typically have infrastructure already built around these specific requirements — bulk-format dispersible tablets, program-appropriate packaging, and documentation formatted for donor agency review.

A Realistic Example of How This Plays Out

Consider a distributor in West Africa sourcing ivermectin tablets for the first time, planning to supply both standard pharmacy channels and a regional onchocerciasis program. An initial outreach to several Indian manufacturers turns up a wide range of quoted prices, with one supplier offering pricing notably below the others.

Before committing, the distributor’s compliance team requests WHO-GMP certificates and COPPs from each shortlisted manufacturer, verifying certificate numbers directly with the relevant Indian state drug authority. Two of the three top candidates check out cleanly. The third, offering the lowest price, provides a certificate that, upon verification, references a different manufacturing address than the one the supplier described during discussions — a discrepancy the supplier is unable to satisfactorily explain when asked directly.

The distributor moves forward with one of the two verified manufacturers, requesting product samples and batch documentation before placing a full order, and separately confirms with the manufacturer whether their facility holds WHO Prequalification status relevant to the regional onchocerciasis program’s donor requirements, which turns out to be the case given the manufacturer’s existing supply relationship with a similar program in a neighboring country.

The extra verification step adds perhaps a week or two to the initial sourcing timeline, but it avoids what could have become a significant compliance and reputational problem — sourcing product from a facility that couldn’t substantiate its own certification claims.

Common Misconceptions About Sourcing from India

“All Indian pharmaceutical manufacturers operate at the same quality standard.” India’s pharmaceutical industry spans an enormous range, from large, multinational-linked manufacturers with sophisticated quality systems to smaller operations with far less mature infrastructure. Treating “made in India” as a single quality signal, in either direction, misses the far more important question of which specific facility manufactured your product and what its actual compliance credentials are.

“A manufacturer’s export volume to other countries guarantees they’ll perform equally well for you.” Strong performance supplying one market doesn’t automatically guarantee the same for a different destination with different regulatory requirements, labeling needs, or logistics realities. Each new market relationship still deserves its own verification process.

“Once you’ve verified a manufacturer, you don’t need to check again.” Compliance status, Import Alert-equivalent flags, and facility conditions can all change over time. Periodic re-verification, particularly for high-volume or long-term relationships, is a sound practice rather than unnecessary caution.

“Lower price always means lower quality, or higher price always means higher quality.” Neither assumption reliably holds. Price reflects a combination of factors — scale, API sourcing, facility overhead, and market positioning — that don’t map cleanly onto quality in either direction. Verification, not price positioning, remains the reliable signal.

“Sourcing directly from a manufacturer is always better than working through a trading company or agent.” For buyers without established relationships or in-country expertise, a reputable trading company or sourcing agent with genuine manufacturer relationships and export experience can add real value, provided they’re transparent about which manufacturer is actually producing your order and don’t obscure the underlying facility’s identity or credentials.

Frequently Asked Questions

Which Indian states manufacture the most ivermectin tablets? Manufacturing is concentrated primarily in Gujarat, Himachal Pradesh (particularly the Baddi region), and Andhra Pradesh/Telangana, though smaller-scale production exists in other pharmaceutical manufacturing regions across the country as well.

Do I need to visit the manufacturing facility before placing an order? It’s not strictly required, but for large or long-term supply relationships, an independent third-party audit or an in-person facility visit is considered a strong due diligence practice, particularly before committing to significant order volumes.

What is the difference between WHO-GMP and WHO Prequalification for sourcing purposes? WHO-GMP certifies that a manufacturing facility meets WHO’s manufacturing quality standards, issued by the national regulator. WHO Prequalification is a separate, more rigorous WHO-administered evaluation of specific products, often required for UN agency and major donor procurement programs. A facility can hold WHO-GMP without any of its products being WHO-prequalified.

How long does it typically take to receive a first shipment after placing an order? Timelines vary based on production scheduling, order volume, and shipping method, but buyers should generally expect several weeks to a few months between order confirmation and shipment arrival, factoring in production, quality release, and international freight.

Can I request a smaller trial order before committing to a full-volume purchase? Many manufacturers, particularly those experienced with international buyers, are open to a smaller initial order or samples to establish trust before scaling to full commercial volumes, though this varies by manufacturer and their standard MOQ policies.

Is it safe to assume a manufacturer’s website claims about certification are accurate? No — independent verification directly with the issuing regulatory authority is a standard and worthwhile due diligence step, regardless of how professional or established a manufacturer’s marketing materials appear.

Do I need a Certificate of Pharmaceutical Product for every country I import into? Many countries require a COPP or equivalent documentation as part of their import registration process, though specific requirements vary by destination. Confirming your specific country’s requirements before sourcing avoids assembling the wrong documentation package.

What should I do if a shipment arrives with different specifications than what was quoted? This is precisely why a written quality agreement and batch-specific Certificate of Analysis matter — they establish the specifications you’re contractually entitled to receive and give you documented grounds to raise a compliance issue with the manufacturer.

Are Indian ivermectin manufacturers generally able to supply dispersible tablet formats? Many established Indian manufacturers offer dispersible tablet formulations alongside standard tablets, given the format’s importance for pediatric dosing and mass drug administration programs, though availability varies by manufacturer and should be confirmed directly.

How do I find reputable Indian ivermectin manufacturers to evaluate? Trade directories, pharmaceutical export promotion council listings, direct outreach to manufacturers with established WHO-GMP certification, and referrals from other distributors or NGO procurement contacts operating in similar markets are all reasonable starting points, though independent verification of any candidate’s credentials remains essential regardless of how you identified them.

Should I work with a single Indian manufacturer or diversify across multiple suppliers? For significant, ongoing volume, many experienced distributors deliberately qualify more than one verified manufacturer, reducing dependency on a single facility’s production capacity and providing a fallback if one supplier experiences a disruption, whether from a regulatory issue, a capacity constraint, or a quality event.

Does India’s domestic pricing for ivermectin reflect export pricing accurately? Not necessarily. Domestic Indian pricing is influenced by local market dynamics and, for certain essential medicines, government price controls, which don’t always translate directly to export pricing that reflects international packaging, documentation, and compliance overhead specific to your target market.

Quick-Reference Glossary

WHO-GMP: A set of manufacturing quality standards published by the World Health Organization, adopted by national regulators to certify pharmaceutical facilities.

COPP (Certificate of Pharmaceutical Product): A document issued under the WHO certification scheme confirming a product is manufactured in a GMP-compliant facility and approved for sale in its country of origin.

API (Active Pharmaceutical Ingredient): The biologically active component of a drug — in this case, the ivermectin compound itself, before formulation into tablets.

MOQ (Minimum Order Quantity): The smallest order volume a manufacturer is willing to accept, which varies based on production batch sizes and manufacturer scale.

WHO Prequalification: A separate, more rigorous WHO-administered evaluation of specific pharmaceutical products, often required for UN agency and major donor procurement programs.

MDA (Mass Drug Administration): A public health strategy involving periodic drug distribution to at-risk populations, a common procurement context for ivermectin in onchocerciasis and other neglected tropical disease programs.

CAPA (Corrective and Preventive Action): The documented process a manufacturer uses to fix a quality problem and prevent recurrence, part of a functioning quality management system.

Site Master File: A document describing a manufacturing facility’s activities, layout, equipment, and quality systems, used by regulators and buyers to assess a plant’s actual capabilities.

Free Sale Certificate: A document confirming a pharmaceutical product is legally sold in its country of manufacture, sometimes required as supporting documentation for import registration in the destination country.

Pharmexcil (Pharmaceuticals Export Promotion Council of India): An Indian government-affiliated body promoting pharmaceutical exports, maintaining member directories that can serve as a starting point for identifying established, export-oriented Indian manufacturers.

Related Reading for Ivermectin and Antiparasitic Buyers

If sourcing from India is one piece of a broader procurement strategy, it’s also worth reviewing:

• How WHO-GMP certification works, for a deeper look at verifying the compliance credential most central to Indian pharmaceutical exports
• Ivermectin tablets vs. other antiparasitic treatments, for a comparative view of where ivermectin fits alongside albendazole, DEC, and praziquantel in a broader sourcing catalog
• How to source ivermectin tablets for NGO and mass drug administration programs, for buyers specifically navigating donor and tender-based procurement
• What a strong pharmaceutical quality agreement should include, regardless of destination market

The Bottom Line

India’s scale and manufacturing depth make it one of the most practical origins for sourcing ivermectin tablets, but scale alone doesn’t substitute for due diligence. The distributors and procurement teams who build reliable, repeatable sourcing relationships are the ones who verify WHO-GMP certification independently, confirm the specific GMP recognition and product registration pathway their destination market actually requires, request and check batch documentation as standard practice, and build written quality agreements into every ongoing relationship rather than relying on certificates alone.

Treat the first order with any new Indian manufacturer as a verification exercise as much as a commercial transaction — request the documentation, check it against the issuing authority, and confirm the specifications hold up in practice before scaling to full volume. That extra diligence upfront is consistently what separates a sourcing relationship that lasts for years from one that ends in a customs hold, a rejected batch, or a scramble to find a replacement supplier mid-contract.

India’s manufacturing base isn’t going anywhere, and the country’s role in global ivermectin supply is likely to remain significant for the foreseeable future given the scale of its API and formulation capacity. The buyers who get the most value out of this supply base long-term are rarely the ones chasing the single lowest quote on a given day — they’re the ones who’ve built a small, carefully vetted roster of manufacturers they trust, verified thoroughly at the outset, and maintained through the kind of ongoing documentation and relationship discipline that turns a first order into a genuinely durable supply chain.